Add Company
Join Now

AlphaVax Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • AlphaVax's estimated annual revenue is currently $1.7M per year.(i)
  • AlphaVax's estimated revenue per employee is $189,444

Employee Data

  • AlphaVax has 9 Employees.(i)
  • AlphaVax grew their employee count by 0% last year.

AlphaVax's People

NameTitleEmail/Phone
1
EVP Development/Technical OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11.2M637%N/AN/A
#2
$5099.8M32902-4%N/AN/A
#3
$1.7M110%N/AN/A
#4
$0.6M4-56%N/AN/A
#5
N/A157%N/AN/A
#6
$0.9M11-39%N/AN/A
#7
$1.7M90%N/AN/A
#8
$0.6M30%N/AN/A
#9
$4.8M31-6%N/AN/A
#10
$6.4M366%N/AN/A
Add Company

What Is AlphaVax?

The AlphaVax pipeline is targeting pandemic influenza and cytomegalovirus (CMV), as well as grant and collaborator-supported programs in HIV, prostate and breast cancer, and several biodefense vaccines. Clinical data from the first alphavaccine human trials have confirmed safety and immunological activity in man. These immune responses are characterized as robust and balanced antibody (B-cell) and cellular (T-cell) immune responses, confirming the promising data we have obtained in over a decade of intensive pre-clinical work with this vector platform.

keywords:N/A

N/A

Total Funding

9

Number of Employees

$1.7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A1138%N/A
#2
N/A1233%N/A
#3
$1.3M13-7%N/A
#4
$2.6M157%N/A
#5
$2.3M1550%N/A